Cargando…
Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
PURPOSE: Patients younger than age 35 that fail to achieve a pathologic complete response (pCR) after Neoadjuvant chemotherapy (NACT) tend to have worse long term outcomes. The purpose of our study was to assess the correlation between the conversion of immunohistochemical (IHC) markers and breast d...
Autores principales: | Zhao, Yue, Wang, Xiaolei, Huang, Yuanxi, Zhou, Xianli, Zhang, Dongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592039/ https://www.ncbi.nlm.nih.gov/pubmed/31417311 http://dx.doi.org/10.2147/CMAR.S198844 |
Ejemplares similares
-
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
por: Cullinane, C., et al.
Publicado: (2022) -
Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
por: Li, Xianjun, et al.
Publicado: (2020) -
Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
por: Zhao, Yue, et al.
Publicado: (2015) -
CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
por: Schlafstein, Ashley J., et al.
Publicado: (2018) -
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
por: Chen, Sheng, et al.
Publicado: (2015)